SCHEMBL26663243

SCHEMBL26663243

CC12CC(C(NC(=O)OCc3ccccc3)C(=O)O)(C1)C2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 12/20 0.51
TSHR P16473 9/20 0.51
CYP2C9 P11712 8/20 0.51
CYP2C19 P33261 7/20 0.51
ALDH1A1 P00352 6/20 0.51
LMNA P02545 2/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
SMN1; SMN2 Q16637 3/20 0.49
CASP1 P29466 1/20 0.49
ATM Q13315 2/20 0.48
CTRB1 P17538 2/20 0.48
CYP1A2 P05177 5/20 0.47
MAPK1 P28482 2/20 0.47
HSD17B10 Q99714 1/20 0.47
CTSK P43235 2/20 0.46
CYP2D6 P10635 3/20 0.46
POLB P06746 1/20 0.46
CTSL P07711 1/20 0.45
CTSS P25774 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30672423 0.88 CYP3A4 (0.46) CYP3A4TSHRCYP2C9CYP2C19ALDH1A1
SCHEMBL30672389 0.88 CYP3A4 (0.46) CYP3A4TSHRCYP2C9CYP2C19ALDH1A1
SCHEMBL30672465 0.88 CYP3A4 (0.46) CYP3A4TSHRCYP2C9CYP2C19ALDH1A1
SCHEMBL26662873 0.83 SYK (0.49) CYP3A4TSHRCYP2C9CYP2C19ALDH1A1
SCHEMBL8267044 0.83 CYP3A4 (0.52) CYP3A4TSHRCYP2C9CYP2C19ALDH1A1
SCHEMBL31045519 0.83 CYP3A4 (0.52) CYP3A4TSHRCYP2C9CYP2C19ALDH1A1
SCHEMBL26662885 0.82 SYK (0.48) CYP3A4TSHRCYP2C9CYP2C19ALDH1A1
SCHEMBL15149564 0.81 CYP3A4 (0.50) CYP3A4TSHRCYP2C9CYP2C19ALDH1A1
SCHEMBL20299871 0.81 CYP3A4 (0.50) CYP3A4TSHRCYP2C9CYP2C19ALDH1A1
SCHEMBL21800943 0.81 CYP3A4 (0.50) CYP3A4TSHRCYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250346602-A1 LACTAM SUBSTITUTED IMIDAZOPYRIDAZINE IL-17A MODULATORS AND USES THEREOF DICE ALPHA INC (US) 2025-11-13 US disclosed
EP-4525987-A1 LACTAM SUBSTITUTED IMIDAZOPYRIDAZINE IL-17A MODULATORS AND USES THEREOF Dice Alpha, Inc. (US) 2025-03-26 EP disclosed
WO-2023225664-A1 LACTAM SUBSTITUTED IMIDAZOPYRIDAZINE IL-17A MODULATORS AND USES THEREOF DICE ALPHA, INC. (US) 2023-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250346602-A1 LACTAM SUBSTITUTED IMIDAZOPYRIDAZINE IL-17A MODULATORS AND USES THEREOF IL17A, IL15, IL18 CYP3A4 95/4885TSHR 4436/4885CYP2C9 183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.